In this Huberman Lab essentials episode, Huberman explores how nicotine affects the brain and body, examining its impact on cognitive function, physical health, and addiction. He explains nicotine's mechanism of action through acetylcholine receptors and its effects on dopamine, norepinephrine, and appetite regulation. While nicotine can temporarily enhance focus and alertness, Huberman details the serious health risks associated with all delivery methods—from smoking and vaping to smokeless tobacco—including cardiovascular damage, reduced lifespan, and long-term cognitive impairment.
The episode also addresses the neurochemical basis of nicotine addiction and why quitting is so difficult, with most attempts ending in relapse. Huberman reviews evidence-based strategies for cessation, including clinical hypnosis, pharmacological interventions like bupropion, and nicotine replacement therapies. He emphasizes that combining multiple approaches yields the best outcomes and offers practical guidance for navigating withdrawal and maintaining long-term abstinence.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Nicotine works by binding to nicotinic acetylcholine receptors in the brain—receptors that naturally respond to acetylcholine in normal brain function. Upon entering the body through smoking, vaping, or oral contact, nicotine is rapidly absorbed into the bloodstream and produces effects within minutes.
When nicotine reaches the brain, it binds to specific receptor subtypes and activates the mesolimbic reward pathway, connecting the ventral tegmental area to the nucleus accumbens. This triggers [restricted term] release, creating feelings of wellbeing, alertness, and motivation—effects that make nicotine highly reinforcing and difficult to quit.
Nicotine also increases acetylcholine availability, which acts as a neurochemical spotlight enhancing focus and cognitive performance for 30 to 45 minutes. Additionally, it stimulates [restricted term] release from the locus coeruleus, boosting alertness and energy. These combined effects—[restricted term] for motivation, acetylcholine for focus, and [restricted term] for arousal—make nicotine a compelling cognitive enhancer.
Beyond cognitive effects, nicotine targets POMC neurons in the hypothalamus, suppressing appetite and temporarily increasing metabolism by 2–5%. This explains why many people experience increased appetite after quitting.
Nicotine rapidly activates the sympathetic nervous system, increasing heart rate and blood pressure within two to fifteen minutes, with smoking producing the fastest effects. It also causes vasoconstriction, narrowing blood vessels and damaging endothelial tissue, which includes negative effects on penile girth and overall vascular health.
While nicotine induces mental alertness and motivation alongside muscle relaxation—creating an ideal state for mental work—this profile is suboptimal for physical performance. The substance is ineffective for activities requiring fast reactions and coordination, making it a poor choice for enhancing athletic performance.
Nicotine consumption carries serious health risks regardless of delivery method. Cigarette smoke contains 4,000 to 7,000 toxins including tar, ammonia, formaldehyde, and carbon monoxide. Smoking a pack daily reduces lifespan by an estimated 14 years and severely damages endothelial cells, disrupting blood and nutrient delivery throughout the body.
Vaping delivers nicotine even faster than smoking, creating a steeper [restricted term] release that mirrors substances like crack cocaine, making it particularly addictive. Despite containing fewer tars, vaping still damages lungs and endothelial cells, increasing risks for vascular disease, heart attack, stroke, and cognitive decline.
Smokeless tobacco forms like dipping and snuffing increase mouth cancers 50-fold and dramatically raise nasal cancer risks. These methods also impair blood vessels similarly to smoking. Importantly, nicotine itself isn't carcinogenic—the real dangers stem from toxins in tobacco products and their delivery methods. While nicotine drives addiction through [restricted term] pathways, the accompanying toxins cause cancer and cardiovascular disease.
Despite nicotine's acute cognitive benefits, chronic use impairs long-term cognition by disrupting blood flow to the brain, interfering with oxygen and glucose delivery and causing memory deficits that negate any short-term advantages.
Nicotine addiction is notoriously difficult to overcome. Within four hours of the last use, withdrawal symptoms begin as [restricted term] levels drop below natural baseline, creating intense cravings. This neurochemical shift produces both physical symptoms like stomach aches and emotional distress including irritability, with symptoms peaking during the first week when about 75% of people relapse.
The brain adapts to nicotine by lowering its baseline for mood and arousal, making cessation feel emotionally intolerable. Only 5% of people succeed quitting cold turkey, and even among those who initially quit, 65% relapse within a year. Nearly 70% of smokers want to quit but struggle due to nicotine's profound neurochemical effects on [restricted term] regulation and motivation.
Research by Dr. David Spiegel at Stanford shows clinical hypnosis is highly effective, with a single session resulting in 23% of participants quitting—significantly higher than the typical 5% success rate. Hypnosis engages participants in self-directed brain change, leveraging neuroplasticity to rewire neural circuits around nicotine.
[restricted term] ([restricted term]) increases [restricted term] release, supporting sustained levels during withdrawal and raising success rates to about 20%. However, it requires medical supervision due to seizure risk. Nicotine replacement therapies like patches, gum, and sprays provide nicotine without harmful delivery mechanisms, allowing gradual dose reduction while avoiding the [restricted term] spikes that reinforce addiction.
Studies show combining approaches yields the best results—integrating pharmacological aids with behavioral interventions addresses both [restricted term] maintenance and habit change. Successfully navigating the difficult first week is essential, as is incorporating monthly maintenance hypnosis to reinforce abstinence neural pathways. Finally, avoiding alcohol during and after quitting is crucial, as it significantly heightens relapse risk by disrupting relevant neural circuits and lowering inhibitions.
1-Page Summary
Nicotine acts as a powerful modulator in the brain and body due to its ability to bind to specific brain receptors, notably the nicotinic acetylcholine receptors. These receptors did not evolve because of tobacco or vaping, but because naturally occurring acetylcholine also uses these receptor sites as part of normal brain and body function. Nicotine is a major component of tobacco but is also present in other nightshades like tomatoes, eggplants, and sweet peppers. Upon entering the body—whether through smoking, vaping, or oral/nasal contact—nicotine is rapidly absorbed into the bloodstream and exerts effects within minutes, depending on the delivery method.
When nicotine reaches the brain, it mainly binds to the alpha-4 beta-2 subtype of nicotinic acetylcholine receptors found in various brain regions. A key area influenced is the mesolimbic reward pathway, which connects the ventral tegmental area (VTA) to the nucleus accumbens. Nicotine stimulates the release of [restricted term] in the nucleus accumbens, which creates transient feelings of wellbeing, alertness, and motivation.
Nicotine also causes the VTA to release additional neurochemicals that further increase [restricted term] in the nucleus accumbens. This robust surge in [restricted term] is responsible for the rewarding properties of nicotine, driving the powerful reinforcement that underlies the difficulty in quitting. The result is greater motivation and a feel-good state that draws users back to nicotine.
Acetylcholine, a fundamental neuromodulator, is released in the brain by neurons in the nucleus basalis and brainstem. The release of acetylcholine acts as a neurochemical spotlight, enhancing the activity of neural circuits linked to ongoing tasks by highlighting where attention is focused.
Nicotine increases the availability of acetylcholine at these critically important sites, boosting mental focus and cognitive performance for 30 to 45 minutes. This effect is short-lived but potent, supporting mental clarity and the ability to concentrate sharply for a brief period.
Nicotine also stimulates the release of [restricted term] from the locus coeruleus, located at the back of the brain. This neurotransmitter surge enhances alertness, arousal, and energy, making the user feel invigorated and ready for action.
The combined neurochemical effects—[restricted term] for motivation, acetylcholine for focus, and [restricted term] for arousal—make nicotine a compelling cognitive enhancer. Users typically feel more motivated, emotionally elevated, sharply focused, and physically alert.
Within the hypothalamus, nicotine binds to alpha-4 beta-2 receptors located on POMC (pro-opiomelanocortin) neurons. This binding increases POMC neuron activity, directly suppressing appetite and reducing food cravings.
Nicotine also causes a moderate, transient boost in metabolism, typically increasing it by 2–5%. This effect is temporary, but many people who stop using nicotine report increased appetite and food intake due to the loss of this app ...
Nicotine's Neurobiology: Brain Receptor Binding and Neurotransmitter Effects
Nicotine consumption, whether by smoking, vaping, dipping, or snuffing, carries serious health risks that extend across nearly every cell, tissue, and organ system. These dangers stem from both the method of nicotine delivery and the numerous toxins in tobacco products, leading to cellular harm, elevated cancer risk, cardiovascular effects, and cognitive decline.
Cigarette smoke contains an estimated 4,000 to 7,000 toxins. Among them, tar, ammonia, formaldehyde, and carbon monoxide are all potent carcinogens. Even "low-tar" cigarettes still contain these harmful substances. Each puff directly introduces these toxins to the lungs, bloodstream, and organs.
The negative health impact of cigarettes is stark. For every pack of cigarettes smoked per day, individuals lose an estimated 14 years off their expected lifespan. Smoking literally peels years off life, and the reduction in lifespan scales with the number of packs smoked.
Smoking inflicts direct damage on endothelial cells—the critical lining of blood vessels responsible for delivering blood and nutrients throughout the body. This cellular harm negatively affects all tissues and organs, including reproductive organs, causing effects such as reduced penis size and greatly impairing the vascular system overall.
Vaping devices work by heating a liquid, not burning tobacco, but they deliver nicotine exceptionally quickly into the bloodstream. This rapid absorption mimics the onset of psychoactive substances like crack cocaine, producing a steep and fast [restricted term] spike in the brain's reward pathway (mesolimbic system). This steep spike makes vaping particularly habit-forming and addictive, potentially more so than smoking traditional cigarettes.
Despite sometimes containing fewer tars than cigarettes, vaping still damages the lungs and endothelial cells, raising the risk for conditions like peripheral vascular disease, heart attack, stroke, and cognitive decline. The direct effects of vaping on endothelial tissue match the negative vascular effects seen with smoking.
The key factor in vaping’s addictiveness is not just the amount of [restricted term] released but how rapidly that level rises. A swift change in [restricted term] concentration, as with vaping, deeply reinforces the habit, solidifying vaping’s position as a highly addictive activity, much like crack cocaine.
Forms of smokeless tobacco such as dipping and snuffing are no safer. Dipping causes a 50-fold increase in mouth cancers, including leukoplakia, while snuffing dramatically raises the risk of nasal cancers. These practices expose mucosal linings to potent carcinogens, leading to severe health risks.
Beyond cancer, smokeless tobacco shares a common pathway of harm with smoking and vaping: damage to the endothelial cells lining blood vessels. This endothelial dysfunction can lead to broad systemic health problems similar to those caused by smoking.
Nicotine Health Risks: Dangers of Smoking, Vaping, Dipping, and Snuffing, Including Endothelial Cell Damage, Cancer Risks, and Cardiovascular Effects
Nicotine addiction persists as one of the most difficult dependencies to overcome, driven by profound neurochemical changes and resulting in severe withdrawal symptoms once use stops.
Within just four hours of the last cigarette, vape, or other form of nicotine intake, withdrawal symptoms begin. Agitation and intense cravings set in as the [restricted term] levels, previously elevated by nicotine, rapidly drop below their natural baseline. The craving for nicotine, while often described vaguely, is actually a precise biological response to this neurochemical shift: a direct consequence of the [restricted term] deficit created when nicotine is suddenly absent from the system. Without nicotine-induced [restricted term] surges, the brain’s [restricted term] level sinks lower than it would be if the individual had never used nicotine at all. This marked decrease forms the biological urge to use nicotine again.
The process of withdrawal quickly escalates in intensity. In addition to cravings, individuals experience a mix of physical symptoms, including stomach aches and nausea, alongside emotional distress like irritability. These symptoms tend to co-occur, creating a deeply unpleasant state that becomes particularly acute during the first week after quitting. This period is critical: about 75% of those attempting to quit relapse quickly due to a considerably worsened emotional state.
Nicotine directly alters the brain’s baseline for mood, arousal, and [restricted term], calibrating it to be lower as a counterweight to the repeated [restricted term] surges from nicotine use. When nicotine is discontinued, the baseline for emotional wellbeing and motivation remains suppressed for a period, which is why cessation can feel emotionally intolerable, with an overall state below the natural set point for both mood and arousal.
The neurochemical grip of nicotine shapes both the likelihood of quitting and the risk of relapse. Only 5% of people who attempt to quit “cold turkey” succeed—meaning they stop without any external support or pharmacologic aid. Even for those who do manage initial cessation, 65% will relapse within a year. This difficulty is largely ...
Nicotine Addiction: Neurochemistry, Quitting Challenges, and Withdrawal Symptoms
Successfully quitting smoking or vaping remains a significant challenge. Evidence reveals that combining diverse strategies—including hypnosis, pharmacological intervention, and nicotine replacement—can boost success rates and address both chemical dependency and behavioral components of tobacco addiction.
Research led by Dr. David Spiegel at Stanford School of Medicine demonstrates hypnosis as a powerful tool for quitting nicotine. In Dr. Spiegel’s studies, a single session of clinical hypnosis resulted in 23% of participants quitting smoking, a dramatic increase over the typical 5% success rate without intervention. Clinical hypnosis engages the participant in self-directed brain change, helping them rewire neural circuits and reshape expectations around nicotine. This approach, rooted in leveraging neuroplasticity, is effective not only for cigarette smoking but also for vaping and other forms of nicotine use.
[restricted term], more commonly known by its trade name [restricted term], operates as both an antidepressant and a tool for smoking cessation. It increases release of [restricted term] and, to a lesser extent, epinephrine in the brain, supporting sustained [restricted term] levels during withdrawal. This stabilization counteracts the typical mood drops and withdrawal symptoms that accompany quitting nicotine. Importantly, [restricted term] raises cessation success rates to about 20%, similar to clinical hypnosis, but requires medical supervision due to a risk of seizures. By providing neurochemical stability, [restricted term] eases emotional distress and reduces the tendency to relapse.
Nicotine replacement therapies (NRT)—such as patches, gum, and sprays—offer nicotine without the harmful delivery mechanisms of smoking or vaping. These tools allow users to maintain steady levels of nicotine, avoiding the [restricted term] spikes that reinforce addiction, while gradually reducing their dosage over time. Rotating weekly between patches, gum, and nasal sprays appears especially effective at minimizing relapse risk. By lowering the nicotine dose progressively, NRT supports withdrawal management and helps break dependence with less disruption to mood and motivation.
Studies show that combining pharmacological aids and behavioral interventions produces the best cessation results. For example, integrating nicotine replacement with hypnosis or [restricted term] leverages neurochemical regulation and behavioral modification. This combined attack addresses both [restricted term] maintenance to reduce withdrawal symptoms and behavioral retraining to change habits, greatly enhancing the odds of long-term abstinence.
The initial week after quitting stands as the most difficult phase in cessation. During this period, 75% of individ ...
Evidence-Based Strategies For Smoking Cessation: Hypnosis, Buprenorphine, and Nicotine Replacement Success Rates
Download the Shortform Chrome extension for your browser
